claudication

(redirected from Cilostazol)
Also found in: Dictionary, Medical, Legal, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for claudication

disability of walking due to crippling of the legs or feet

References in periodicals archive ?
Cilostazol with its medicinal properties will enjoy a large market and play an important role in future.
Pharmacodynamic interaction study of Allium sativum (garlic) with cilostazol in patients with type II diabetes mellitus.
They exceed the improvements reported for other conventional PAD drug therapies including pentoxifylline, cilostazol, dipyridamole, ticlopidine, beraprost, iloprost, naftidrofuryl, and statins, Dr.
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial.
Authors Dr Deepak Bhatt and Dr Dharam Kumbhani of Harvard Medical School, said the trial suggested that cilostazol offered "prevention beyond the protection provided by aspirin".
Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells.
Cilostazol therapy in optimal doses made no improvement in her symptoms of left arm pain at rest and claudication.
Clinical data and the opinions of interviewed thought leaders indicate that Aastrom Biosciences' ixmyelocel-T and PLX-PAD have advantages over cilostazol (Otsuka's Pletaal/Pletal, generics) on this attribute.
SAN DIEGO, May 8, 2015 /PRNewswire/ -- Patients with a high-risk paclitaxel drug-eluting stent who were given the shorter-acting antiplatelet drug cilostazol prior to a surgical procedure safely transitioned off of dual antiplatelet therapy (DAPT) to reduce the risk of bleeding during their operation.
The phosphodiesterase, inhibitor cilostazol has shown 32%-82% improvements in PFWT and MWT Pentoxifylline, another phosphodiesterase inhibitor, produced a 12% gain in MWT And exercise training has shown a 150% improvement in both MWT and PFWT.
Blood thinners such as pentoxifyline (Trental) and Cilostazol (Pletal) are also prescribed.
Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, et al; Cilostazol for Restenosis Trial (CREST) Investigators.
Of the two FDA-approved pharmacologic agents for treating claudication, data suggest that cilostazol is superior to pentoxifylline.
11 Effect of Early Cilostazol in the Acute Phase of Non-Cardioembolic Stroke